JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,196,000 | $18,756,000 | $13,278,000 | $30,733,000 |
| Short-Term Investments | $0 | $0 | $0 | $244,000 |
| Receivables | $12,236,000 | $14,934,000 | $11,137,000 | $15,585,000 |
| Inventory | $21,758,000 | $20,933,000 | $18,514,000 | $14,636,000 |
| Other Curr. Assets | $3,866,000 | $2,958,000 | $4,873,000 | $990,000 |
| Total Curr. Assets | $51,056,000 | $57,581,000 | $47,802,000 | $62,188,000 |
| Property Plant & Equip (Net) | $37,410,000 | $30,040,000 | $32,681,000 | $26,782,000 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2,960,000 | $3,496,000 | $3,652,000 | $2,960,000 |
| Long-Term Investments | $10,442,000 | $9,120,000 | $9,443,000 | $2,769,000 |
| Tax Assets | $2,985,000 | $0 | $1,357,000 | $2,433,000 |
| Other NC Assets | $0 | $1,989,000 | $0 | $0 |
| Total NC Assets | $53,797,000 | $44,645,000 | $47,133,000 | $34,944,000 |
| Other Assets | $2,000 | $0 | $2,000 | $2,000 |
| Total Assets | $104,855,000 | $102,226,000 | $94,937,000 | $97,134,000 |
| Liabilities | – | – | – | – |
| Payables | $590,000 | $890,000 | $1,563,000 | $1,324,000 |
| Short-Term Debt | $26,055,000 | $8,908,000 | $17,300,000 | $15,150,000 |
| Tax Payable | $36,000 | $1,657,000 | $33,000 | $5,915,000 |
| Deferred Revenue | $0 | $1,657,000 | $3,924,000 | $12,108,000 |
| Other Curr. Liab. | $17,307,000 | $16,981,000 | $16,866,000 | $19,665,000 |
| Total Curr. Liab. | $43,988,000 | $30,135,000 | $35,762,000 | $42,054,000 |
| LT Debt | $12,050,000 | $14,350,000 | $5,573,000 | $2,950,000 |
| Deferred Rev, NC | $0 | $0 | -$428,000 | -$343,000 |
| Deferred Tax Liab, NC | $0 | $0 | $428,000 | $343,000 |
| Other NC Liab. | $1,382,000 | $1,267,000 | $1,190,000 | $1,044,000 |
| Total NC Liab. | $13,432,000 | $15,617,000 | $6,763,000 | $3,994,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | -$42,000 | $73,000 | $0 |
| Total Liabilities | $57,420,000 | $45,752,000 | $42,525,000 | $46,048,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9,061,000 | $9,061,000 | $9,061,000 | $9,061,000 |
| Retained Earnings | $31,191,000 | $37,278,000 | $34,273,000 | $33,241,000 |
| AOCI | $1,463,000 | $2,416,000 | $1,421,000 | $0 |
| Other Equity | $5,326,000 | $7,423,000 | $7,406,000 | $8,579,000 |
| Total Equity | $47,040,000 | $56,178,000 | $52,161,000 | $50,881,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $392,000 | $297,000 | $251,000 | $205,000 |
| Total Liab. & Tot. Equity | $104,460,000 | $102,226,000 | $94,937,000 | $97,134,000 |
| Net Debt | $24,909,000 | $4,502,000 | $9,595,000 | -$12,633,000 |